Sterling Capital Management LLC Tg Therapeutics, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 142 shares of TGTX stock, worth $4,955. This represents 0.0% of its overall portfolio holdings.
Number of Shares
142Holding current value
$4,955% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TGTX
# of Institutions
331Shares Held
93.1MCall Options Held
1.72MPut Options Held
1.29M-
Vanguard Group Inc Valley Forge, PA15.4MShares$537 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$397 Million0.0% of portfolio
-
State Street Corp Boston, MA9.09MShares$317 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V83.58MShares$125 Million0.1% of portfolio
-
Geode Capital Management, LLC Boston, MA3.21MShares$112 Million0.01% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.07B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...